30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Synthorx Inc (THOR)

Track

The most recent insider trading activity at Synthorx Inc. occurred on December 11, 2018. On this date, several significant buy transactions were executed by various insiders and entities, totaling over $130 million. These purchases represent a substantial influx of capital from key stakeholders.
Stock chart
Ticker: THOR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RA CAPITAL MANAGEMENT, LLC
1 purchase — total 50,000,005 USD
Buy 11 Dec 2018
Value US$1,514,348.55 | Price 230.17 | Shares 5,298
Buy 11 Dec 2018
Value US$4,377,109.43 | Price 263.71 | Shares 90,248
Buy 11 Dec 2018
Value US$14,999,996.00 | Price 11.00 | Shares 1,363,636
Buy 11 Dec 2018
Value US$14,999,996.00 | Price 11.00 | Shares 1,363,636
Buy 11 Dec 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 11 Dec 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 11 Dec 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-12-13 2018-12-11 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
5,298 -14.6%
230.17
US$1,514,349 		5,298 -14.6% 230.17 US$1,514,349
2018-12-13 2018-12-11 B Purchase Kolchinsky Peter Non-Executive Director Large shareholder
90,248 -23.4%
263.71
US$4,377,109 		90,248 -23.4% 263.71 US$4,377,109
2018-12-13 2018-12-11 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
26,557 +7.8%
256.02
US$3,974,782 		26,557 +7.8% 256.02 US$3,974,782
2018-12-13 2018-12-11 B Purchase Thompson Peter A. Non-Executive Director Large shareholder
1,363,636 +34.5%
11.00
US$14,999,996 		1,363,636 +34.5% 11.00 US$14,999,996
2018-12-13 2018-12-11 B Purchase Reardon Tighe

Acting Chief Financial Officer

Officer
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
2018-12-13 2018-12-11 B Purchase Lichter Jay Non-Executive Director Large shareholder
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
2018-12-13 2018-12-11 B Purchase Avalon Ventures X, L.P. Large shareholder
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
Explore more

More insider trading research around Synthorx Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America